首页> 外文OA文献 >Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements

【2h】

Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements

机译：基于生物的SiRNA的纳米载体靶向分子信号传导途径，用于治疗三重阴性乳腺癌：临床前和临床进步

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Dima Hattab; Athirah Bakhtiar;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. [J] . King TD, Suto MJ, Li Y Journal of cellular biochemistry. . 2012 ,第1期

机译：Wnt /β-catenin信号通路：三阴性乳腺癌的潜在治疗靶点。
2. Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer [J] . Li Wenlong, Yang Hongmei, Li Xiaoli, Oncology reports . 2019 ,第1期

机译：信号通路抑制剂靶向三阴性乳腺癌中的乳腺癌干细胞
3. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/beta-catenin and TGF beta signaling pathways [J] . Cruz-Lozano Marina, Gonzalez-Gonzalez Adrian, Marchal Juan A., European journal of nutrition . 2019 ,第8期

机译：通过同时靶向上皮 - 间充质转换，WNT /β-连环蛋白和TGFβ信号传导途径，羟基吡咯醇抑制癌症干细胞和三阴性乳腺癌细胞系的转移能力
4. Nanobody-Conjugated, Quantum Dot-Based Unimolecular Micelles for Targeted Triple Negative Breast Cancer #Therapy [C] . Yuyuan Wang, Yidan Wang, Guojun Chen, Society for Biomaterials annual meeting and exposition . 2017

机译：纳米抗体缀合，基于量子点的单分子胶束用于靶向三阴性乳腺癌＃疗法
5. Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers. [D] . Weng, Shu-Chuan. 2008

机译：在三阴性和HER2 / neu阳性乳腺癌中作为抗癌药的新型小分子的临床前探索。
6. Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements [O] . Dima Hattab, Athirah Bakhtiar 2020

机译：基于生物的SiRNA的纳米载体靶向分子信号传导途径用于治疗三重阴性乳腺癌：临床前和临床进步
7. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways [O] . 2017

机译：Syndecan-1是三阴性炎症性乳腺癌的新型分子标记，可通过IL-6 / STAT3，Notch和EGFR信号通路调节癌症干细胞表型

Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements

著录项

相似文献

相关主题

期刊订阅